Posters

Femtosecond laser-assisted cataract surgery in eyes with phakic intraocular lenses

Poster Details

First Author: F.Hengerer GERMANY

Co Author(s):    G. Auffarth   I. Conrad-Hengerer                 

Abstract Details

Purpose:

To perform capsulotomy and lens fragmentation with a Femtosecondlaser platform through different types of phacic IOLs implanted for refractive corrections.

Setting:

Dept. of Ophthalmology, University of Heidelberg, Germany

Methods:

Three eyes of two patients with either ICL (Staar) or Cachet IOL (Alcon) with senile cataract were evaluated. Standard laser settings for capsulotomy diameter and lens fragmentation were applied after sufficient pupillary dilation. Detection of intraocular surface of both pIOL and natural lens was possible in all cases. Explantation of the phacic IOLs was done before phacoemulsification and aspiration of lens capsules and lens fragments. Explanted IOLs were examined by means of Light Microscopy. Intraoperative complications were recorded.

Results:

All capsulotomies were free floating without tags or bridges. Gas bubble formation did not cause any side effects prohibiting the laser fragmentation of the natural lens. Explanted IOLs did not present any damage caused by laser-application and in all cases a single piece IOL could be implanted in the capsular bag.

Conclusions:

Femtolaser-assisted capsulotomy and lens fragmentation can be performed safely with a pIOL in place. This approach offers the surgeon a stable platform with a perfectly centered capsulotomy for individual selection of suitable IOLs to address the refractive patients�Â�´ needs for visual recovery.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non-monetary benefits from a competing company., receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented., receives consulting fees, retainer, or contract payments from a competing company